Diagnostic and Management Approach for Refractory GERD

Diagnostic Evaluation

For patients with GERD uncontrolled on high-dose PPI therapy, endoscopy with complete evaluation is recommended, including inspection for erosive esophagitis, diaphragmatic hiatus assessment, hiatal hernia measurement, and Barrett's esophagus screening. 1, 2
pH/impedance monitoring should be performed to determine if persistent symptoms are related to acid or non-acid reflux, allowing diagnosis of increased acid exposure, symptom association, and identification of phenotypes (non-erosive reflux disease, hypersensitive esophagus, functional heartburn). 1, 3
pH/impedance monitoring should be conducted while the patient remains on PPI therapy to determine the mechanism of persisting symptoms despite treatment. 1, 2

PPI administration should be properly timed (30-60 minutes before meals) to optimize effectiveness. 4
Lifestyle modifications should be reinforced, including weight management, avoiding meals within 3 hours of bedtime, elevating head of bed, and avoiding trigger foods. 1, 4
Adjunctive therapy should be personalized based on symptom pattern, including alginate antacids for breakthrough symptoms, nighttime H2-receptor antagonists for nocturnal symptoms, baclofen (5-20 mg TID) for regurgitation or belch-predominant symptoms, and prokinetics for coexistent gastroparesis. 2, 5
For patients with confirmed pathological acid reflux, consider switching to a different PPI (esomeprazole or dexlansoprazole). 4
For patients with non-acid reflux or hypersensitive esophagus, neuromodulators should be added to the treatment regimen. 1, 2
Patients with functional heartburn should receive pharmacologic neuromodulation and/or referral for behavioral therapy. 1, 2
The American Gastroenterological Association recommends against continuing empiric therapy beyond twice-daily PPI without objective testing. 5

For patients with confirmed GERD who remain symptomatic despite optimized medical therapy, antireflux surgery should be considered. 6, 7
Surgical intervention has shown 85-100% improvement in chronic cough and other GERD symptoms in patients who failed intensive medical therapy. 6, 7
Patients with non-acid reflux may not respond to even high-dose PPI therapy and might benefit from surgical intervention. 6, 7